Study: Omega-3 Polyunsaturated Fatty Acids Linked to Reduced Anxiety Symptoms

Gina Kokosky, Assistant Editor
Published Online: Monday, October 1st, 2018
An analysis of 19 clinical studies shows that an association exists between omega-3 polyunsaturated fatty acid treatment (PUFAs) and a reduced severity of anxiety symptoms. Researchers have concluded that omega-3 PUFAs may be clinically effective in treating anxiety symptoms, according to a study published by JAMA Network.

Patients with anxiety experience inappropriate and amplified feelings of fear, causing distress and impairing one's daily life. Anxiety is currently the most common psychiatric symptom, with 1 in 3 adults reporting an anxiety disorder in their lifetime. Anxiety is often comorbid with depressive disorders. The combination of these debilitating disorders can reduce a patient’s health-related quality of life, and increase their risk of mortality, according to the study.

Treatment options for patients with anxiety include cognitive behavioral therapy or pharmaceuticals, such as selective serotonin reuptake inhibitors. Some patients with anxiety, however, may be hesitant to take medications with potential adverse effects or participate in costly and time consuming behavioral therapy. Therefore, novel treatment options for patients with anxiety and comorbid medical conditions are necessary for wider access to treatment, according to the study.

Continue reading at

Current Issue

The Educated Patient

Bethany Rettberg, NPC
Practitioners should get a detailed medical history and conduct a thorough physical to treat sinus infections.
Jennifer L. Hofmann, MS, PA-C
Providing them with advice can improve control of the disease and reduce hospitalizations, morbidity, and unscheduled health care visits.
Emily C. Hayes, PharmD Candidate
Colds, coughs, and a relentless influx of sick patients in retail health clinics keep the health care providers who work there very busy.
Kristen Marjama, DNP, APRN-BC
Although the rate of foot and leg amputation has greatly declined over the past 2 decades, increasing awareness for macrovascular and microvascular complications of diabetes is essential because diabetes is the leading cause of lower-limb amputations in the United States.
$vacMongoViewPlus$ $vAR$
Contemporary Clinic
MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Specialty Pharmacy Times
Targeted Oncology
About Us
Contact Us
Terms & Conditions
Pharmacy Healthcare & Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-257-0701

Copyright Contemporary Clinic 2018
Pharmacy Healthcare & Communications, LLC. All Rights Reserved.